We showed in a previous study that FXR constructed an immunosuppressive TME in FXRhiPD-L1lo NSCLC, shown as a decrease in cytotoxic CD8+ T cells (16). This evidence concerns the gene NR1H4 and non-small cell lung carcinoma.